Celgene posts pivotal CAR-T data ahead of FDA filing

Celgene posts pivotal CAR-T data ahead of FDA filing

Source: 
Fierce Biotech
snippet: 

Celgene has posted data from a pivotal trial of its CAR-T therapy. The data look competitive against Gilead’s Yescarta and Novartis’ Kymriah, leading analysts to predict Celgene will win FDA approval next year.